CA-17-QL18_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, (2S)-4-cyclohexyl-2-[[1-[(4-nitrophenyl)methyl]-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]amino]butanoic acid, Angiotensin AT2 Antagonists targeting AGTR2 (Novartis, 22878749)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/22878749
Similar Terms
Downloads & Tools

Genes

2 genes differentially expressed following the CA-17-QL18_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
MYL6 myosin, light chain 6, alkali, smooth muscle and non-muscle 0.213029

decreased expression

Symbol Name Standardized Value
LEMD2 LEM domain containing 2 -0.248777